OCTANATE

This brand name is authorized in Austria, Ecuador, Estonia, Spain, France, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug OCTANATE contains one active pharmaceutical ingredient (API):

1 Factor VIII (antihemophilic factor)
UNII 839MOZ74GK - ANTIHEMOPHILIC FACTOR HUMAN

Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.

Read about Coagulation factor VIII

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BD02 Coagulation factor VIII B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29216-04-10, 98-MBE-0417
Country: EE Ravimiamet Identifier(s): 1080076, 1080087
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 79616, 79617
Country: FR Base de données publique des médicaments Identifier(s): 63356814, 64343816, 67301879, 69098993
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 399942, 399945
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-067222873, HR-H-748572974
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8321, 8322
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004633, 1004634, 1004635, 1072376, 1072377
Country: MT Medicines Authority Identifier(s): MA1219/00701, MA1219/00702, MA1219/00703, MA1219/00704, MA1219/00705
Country: NL Z-Index G-Standaard, PRK Identifier(s): 45438, 45446, 45454
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 12482, 12485, 12486
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100237035, 100237041, 100333320, 100333336
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65351001, W65352001, W65353001, W65353002, W65354001
Country: SG Health Sciences Authority Identifier(s): 12512P, 12513P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 10033022H, 10033023H, 10043051H, 10043052H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699686980113, 8699686980120
Country: ZA Health Products Regulatory Authority Identifier(s): 36/30.2/0346, 36/30.3/0344, 36/30.3/0345

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.